The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
Medical device major, Medtronic plc MDT recently received the U.S. FDA 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. The device is an advanced cardiac ...
The latest clinical trial results for Medtronic's ($MDT) insertable cardiac monitor show that it's effective at detecting atrial fibrillation at an even higher rate ...
Medtronic's Reveal Linq wireless cardiac monitoring implant--Courtesy of Medtronic The world's smallest cardiac monitor implant is on track to make a move into the ...
AUSTIN, Texas, March 19, 2014 /PRNewswire/ -- On Feb. 27, 2014, Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center was among the first in the United States to implant the ...
Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke DUBLIN - Sept. 14, 2016 - Medtronic plc (MDT) today announced it has received Ministry of Health, Labor and ...
The University of Michigan Frankel Cardiovascular Center is one of the nation's first hospitals to use the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System, the smallest implantable ...
DUBLIN, Medtronic plc today announced the first in-office implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study. The world's smallest cardiac ...
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback